{"id":9447,"date":"2026-09-21T15:35:37","date_gmt":"2026-09-21T13:35:37","guid":{"rendered":"https:\/\/mumak.me\/?p=9447"},"modified":"2026-10-11T00:32:52","modified_gmt":"2026-10-10T22:32:52","slug":"weekly-market-overview-september-7-september-13-2026","status":"publish","type":"post","link":"https:\/\/mumak.me\/en\/portfolio-updates\/weekly-update\/weekly-market-overview-september-7-september-13-2026\/","title":{"rendered":"Weekly Market Overview \u2013 September 14-September 20, 2026"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The past week was marked by a stronger technology focus and further portfolio adjustments within the UMBRELLA Strategy<\/strong>. Intel<\/strong> and Alphabet<\/strong> were newly added to the portfolio, while the position in MercadoLibre<\/strong> was reduced.<\/p>

At the same time, Rheinmetall<\/strong> and Revolution Medicines<\/strong> traded particularly close to their defined stop-loss zones and were therefore under close observation.<\/p>

Following the adjustments, the UMBRELLA Strategy comprises 12 positions<\/strong>. The equity allocation stands at approximately 99.7%<\/strong>, with cash at around 0.3%<\/strong>.<\/p>

Healthcare remains the largest portfolio focus<\/strong><\/h2>

Revolution Medicines<\/strong> remained the largest position with a weighting of approximately 17%<\/strong>. Together with Johnson & Johnson<\/strong>, Eli Lilly<\/strong>, and Bayer<\/strong>, the company formed the core of the strategy’s healthcare exposure.<\/p>

Revolution Medicines<\/strong> was among the positions under particularly close observation during the past week, as the stock approached its defined stop-loss zone. No portfolio adjustment was made.<\/p>

The company also drew attention following further regulatory progress for RASONQUE\u2122. This includes the FDA’s Breakthrough Therapy designation for a combination therapy as first-line treatment for metastatic pancreatic cancer.<\/p>

Intel added to the UMBRELLA Strategy<\/strong><\/h3>

One of the week’s most significant portfolio changes was the addition of Intel with an initial weighting of approximately 3%<\/strong>.<\/p>

The position reflects the turnaround potential of Intel<\/strong> as well as the company’s strategic importance for semiconductor manufacturing. Intel<\/strong> is among the few Western semiconductor companies that combine chip design, fabrication, and advanced packaging technologies.<\/p>

Government initiatives to expand domestic semiconductor capacity in the U.S. and Europe could support Intel’s<\/strong> long-term strategic position.<\/p>

Alphabet added to the UMBRELLA Strategy<\/strong><\/h3>

Alphabet<\/strong> was also newly added with an initial weighting of approximately 4%<\/strong>.<\/p>

The addition was based on the company’s fundamental strength, positive analyst assessment, and constructive technical picture. Alphabet<\/strong> expands the strategy’s exposure to artificial intelligence, cloud infrastructure, and digital platforms<\/strong>.<\/p>

Intel and Micron strengthen semiconductor exposure<\/strong><\/h3>

Following the addition of Intel<\/strong>, the UMBRELLA Strategy now holds two targeted semiconductor positions.<\/p>

Intel<\/strong> and Micron Technology<\/strong> cover different segments of the semiconductor value chain. Intel<\/strong> represents the strategic expansion of Western chip production, while Micron Technology<\/strong> specializes in memory solutions and benefits from growing demand for AI infrastructure and high-bandwidth memory.<\/p>

MercadoLibre position reduced<\/strong><\/h3>

The position in MercadoLibre<\/strong> was reduced from approximately 8.5% to around 4.5%<\/strong> due to continued weakness in the broader technical trend.<\/p>

The company remains part of the UMBRELLA Strategy and provides exposure to e-commerce and digital financial services in Latin America<\/strong>.<\/p>

SpaceX and Palantir remain core growth positions<\/strong><\/h3>

Beyond healthcare and semiconductors, the portfolio combines several structural growth themes.<\/p>

SpaceX<\/strong> and Palantir Technologies<\/strong> remain important technology and growth positions within the UMBRELLA Strategy. SpaceX<\/strong> provides exposure to commercial space infrastructure, while Palantir Technologies<\/strong> represents the portfolio’s focus on artificial intelligence, data analytics, and software platforms.<\/p>

Together with Alphabet<\/strong>, Intel<\/strong>, and Micron Technology<\/strong>, these positions have strengthened the portfolio’s focus on advanced technologies.<\/p>

Rheinmetall remains under close observation<\/strong><\/h3>

Rheinmetall<\/strong> traded particularly close to its defined stop-loss zone during the week and was therefore under close observation.<\/p>

The company remains part of the strategy’s selective exposure to the European defense sector. From a risk management perspective, however, the stock’s technical development is particularly relevant.<\/p>

Current positioning of the UMBRELLA Strategy<\/strong><\/h3>

Following the recent adjustments, the UMBRELLA Strategy comprises 12 positions<\/strong>.<\/p>

Healthcare remains the largest allocation, complemented by selected exposures to artificial intelligence, semiconductors, advanced technologies, digital commerce, and European defense<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\"Allocation\t<\/a>\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Source: wikifolio, September 21, 2026.<\/em><\/p>

Outlook: Technology and risk management in focus<\/strong><\/h3>

The UMBRELLA Strategy enters the new week with 12 positions and a cash allocation of approximately 0.3%<\/strong>.<\/p>

Following the addition of Intel<\/strong> and Alphabet<\/strong>, the portfolio has expanded its exposure to artificial intelligence, semiconductors, and advanced technologies<\/strong>. Healthcare nevertheless remains the strategy’s largest allocation.<\/p>

The focus is on the interplay between fundamental developments and technical signals. Rheinmetall<\/strong> and Revolution Medicines<\/strong> are particularly relevant from a risk management perspective, while the development of the newly added positions Intel<\/strong> and Alphabet<\/strong> is also being closely monitored.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

UMBRELLA Strategy: Technology weighting expanded following portfolio adjustments.<\/p>\n","protected":false},"author":2,"featured_media":2174,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[153],"tags":[613,508,211],"aktie":[],"class_list":["post-9447","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-weekly-update","tag-intel","tag-alphabet","tag-technology"],"acf":[],"_links":{"self":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/9447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/comments?post=9447"}],"version-history":[{"count":7,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/9447\/revisions"}],"predecessor-version":[{"id":9614,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/9447\/revisions\/9614"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/media\/2174"}],"wp:attachment":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/media?parent=9447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/categories?post=9447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/tags?post=9447"},{"taxonomy":"aktie","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/aktie?post=9447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}